InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+23.0%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Levin Alan G, 董事. Director active across 2 companies, notably Biocryst Pharmaceuticals INC. In total, 15 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €46k. History available since 31 August 2021. The latest transaction was disclosed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Levin Alan G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
15,294 股Common StockSEC:0000882796-26-000052:0
12,500 股0Common StockSEC:0001171843-25-003915:0
6,820 股0Common StockSEC:0001127602-24-018725:0
7,861 股@ US$6.3632.3% 占其流量Common StockSEC:0001127602-24-017121:0
标准退出：2024年8月28日 (T+90)
16,745 股0Common StockSEC:0001127602-23-018793:0
1,360 股@ US$8.277.4% 占其流量Common StockSEC:0001127602-23-017556:0
1,271 股@ US$8.857.4% 占其流量Common StockSEC:0001127602-23-008381:0
842 股@ US$13.367.6% 占其流量Common StockSEC:0001127602-22-026825:0
809 股@ US$13.907.8% 占其流量Common StockSEC:0001127602-22-022014:0
12,866 股0Common StockSEC:0001127602-22-017148:0
1,138 股@ US$9.317.9% 占其流量Common StockSEC:0001127602-22-016395:0
602 股@ US$16.617.1% 占其流量Common StockSEC:0001127602-22-007730:0
829 股@ US$12.067.1% 占其流量Common StockSEC:0001127602-21-030059:0
628 股@ US$15.926.7% 占其流量Common StockSEC:0001127602-21-024778:0
248,032 股Common StockSEC:0001437749-16-023549:0
15 条申报中的 15 条
About Levin Alan G
LEVIN ALAN G is Administrateur at Biocryst Pharmaceuticals INC and RestorGenex Corp. He has 15 filings in total, and within the sampled recent filings, the transactions span 2016-01-12 to 2026-06-15, with EUR 46141 of buys and EUR 0 of sells, and the most frequent transaction nature is Attribution.
